Dr Brodeur is a Canadian Psychiatrist and is doing a Visiting Research Fellow as part of the EPIC lab and the OASIS clinic. He has been awarded the 2023 Robert Kerwin Prize by the Royal College of Psychiatrists, Psychopharmacology Committee for his article : Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study. BJP10.1192/bjp.2022.1.

 

Research Interests:

Early intervention, preventive psychiatry, personalised psychiatry, psychopharmacology.

 

Research Groups: 

Early Psychosis: Intervention and Clinical detection Laboratory (EPIC Lab)

 

Orchid ID:

https://orcid.org/0000-0002-7755-

 

key publications:

• Brodeur, S., Courteau, J., Vanasse, A., Courteau, M., Stip, E., Fleury, M., . . . Roy, M. (2022). Association between previous and future antipsychotic adherence in patients initiating clozapine: Real-world observational study. The British Journal of Psychiatry, 220(6), 347-354. doi:10.1192/bjp.2022.1
• Brodeur, S, Vanasse, A, Courteau, J, et al. Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach. Acta Psychiatr Scand. 2022; 145: 469– 480. doi:10.1111/acps.13411
• Brodeur, S, Vanasse, A, Courteau, J, et al. Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study. Acta Psychiatr Scand. 2022; 145: 456– 468. doi:10.1111/acps.13413